S
Live / Registered — Registered (as of 22 Jul 2025)
What this means for you
Registered since 22 Jul 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97207472
- Registration number
- 7870705
- Mark type
- Design + words
- Filed
- 07 Jan 2022
- Published for opposition
- 17 Jan 2023
- Registered
- 22 Jul 2025
- Attorney of record
- Timothy H. Hiebert
Goods and services
- Class 042 — Scientific and technological services: Pharmaceutical research and development in the fields of genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, targeted genomic insertion, targeted genomic integration, genetic diseases, gene therapy and cell therapy; Medical laboratory services in the nature of gene editing for developing cells and protein RNA complexes for medical use
Owner
- Editas Medicine, Inc., Cambridge, MA, US
- Editas Medicine, Inc., Cambridge, MA, US
- Editas Medicine, Inc., Cambridge, MA, US
Prosecution history
- 22 Jul 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 22 Jul 2025 — REGISTERED-PRINCIPAL REGISTER
- 16 Jul 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 27 Jun 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 02 Jun 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 09 Mar 2025 — USE AMENDMENT FILED
- 03 Jun 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 10 Mar 2025 — TEAS STATEMENT OF USE RECEIVED
- 09 Sept 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 Sept 2024 — SOU EXTENSION 3 GRANTED
- 09 Sept 2024 — SOU EXTENSION 3 FILED
- 09 Sept 2024 — SOU TEAS EXTENSION RECEIVED
- 14 Mar 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 Mar 2024 — SOU EXTENSION 2 GRANTED
- 13 Mar 2024 — SOU EXTENSION 2 FILED